BioSig Technologies Issues June 2019 Shareholder Letter

June 20, 2019

BioSig Technologies Set to Join Russell 3000® Index

June 10, 2019

BioSig Allowed a U.S. Patent for PURE EP™ Simulator

June 6, 2019

BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises

June 3, 2019

BioSig Technologies to Present at the 9th Annual LD Micro Invitational

May 30, 2019

BioSig Allowed First Key US Patent Claims for its PURE EP™ System

May 23, 2019

Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

May 21, 2019

BioSig Technologies Completes Patient Cases at Indiana University

May 6, 2019

BioSig’s Manuscript Accepted to IEEE Engineering in Medicine and Biology Conference 2019

May 2, 2019

BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019

April 30, 2019